Seyedtaghi Takyar, MD, PhD | American Lung Association

Location Select your location

Seyedtaghi Takyar, MD, PhD

Research Awards Nationwide Recipient (2014-2016)

Yale University, New Haven, CT
Enhancing the Targeting of Tumor Blood Vessels in Lung Cancer

Vascular endothelial growth factor (VEGF) is secreted by lung tumor cells to maintain and enhance the blood vessels in the tumor and in its vicinity supporting further tumor growth and invasion. An anti-VEGF drug is used to treat advanced lung cancer, but its effectiveness is limited as most patients quickly become resistant to its effects. We have found that intracellular concentration of a molecule called microRNA-1 in tumor blood vessels determines their response to VEGF. We will study the effect of this molecule on the growth of blood vessels in lung tumors and their progression in animal models. Our hope is to find a way to prevent resistance to anti-VEGF therapy and to identify a subset of patients who will benefit the most.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.